Controlled release of transforming growth factor ?1 from biodegradable polymer microparticles
- 23 March 2000
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research
- Vol. 50 (3) , 440-451
- https://doi.org/10.1002/(sici)1097-4636(20000605)50:3<440::aid-jbm19>3.0.co;2-g
Abstract
Recombinant human transforming growth factor β1 (TGF-β1) was incorporated into biodegradable microparticles of blends of poly(dl-lactic-co-glycolic acid) (PLGA) and poly(ethylene glycol) (PEG) at 6 ng/1 mg microparticles. Fluorescein isothiocynate labeled bovine serum albumin (FITC-BSA) was coencapsulated as a porogen at 4 μg/1 mg of microparticles. The effects of PEG content (0, 1, or 5 wt %) and buffer pH (3, 5, or 7.4) on the protein release kinetics and the degradation of PLGA were determined in vitro for up to 28 days. The entrapment yield of TGF-β1 was 83.4 ± 13.1 and 54.2 ± 12.1% for PEG contents of 0 and 5%, respectively. The FITC-BSA and TGF-β1 were both released in a multiphasic fashion including an initial burst effect. Increasing the PEG content resulted in the decreased cumulative mass of released proteins. By day 28, 3.8 ± 0.1 and 2.8 ± 0.3 μg (based on 1 mg microparticles) of loaded FITC-BSA and 3.4 ± 0.2 and 2.2 ± 0.3 ng of loaded TGF-β1 were released into pH 7.4 phosphate buffered saline (PBS) from microparticles with 0 and 5% PEG, respectively. Aggregation of FITC-BSA occurred at lower buffer pH, which led to decreased release rates of both proteins. For microparticles with 5% PEG, 2.3 ± 0.1 μg of FITC-BSA and 2.0 ± 0.2 ng of TGF-β1 were released in pH 7.4 buffer after 28 days, while only 1.7 ± 0.3 μg and 1.3 ± 0.4 ng of the corresponding proteins were released in pH 3 buffer. The degradation of PLGA was also enhanced at 5% PEG content, which was significantly accelerated at acidic pH conditions. The calculated half-lives of PLGA were 20.3 ± 0.9 and 15.9 ± 1.2 days for PEG contents of 0 and 5%, respectively, in pH 7.4 PBS and 14.8 ± 0.4 and 5.5 ± 0.1 days for 5% PEG in pH 7.4 and 3 buffers, respectively. These results suggest that PLGA/PEG blend microparticles are useful as delivery vehicles for controlled release of growth factors. © 2000 John Wiley & Sons, Inc. J Biomed Mater Res, 50, 440–451, 2000.Keywords
This publication has 28 references indexed in Scilit:
- Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disordersBiomaterials, 1999
- Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: Release kinetics and stability issuesJournal of Microencapsulation, 1998
- Polypeptide growth factors: targeted delivery systemsBiomaterials, 1997
- Inhibition of smooth muscle cell growthin vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticlesJournal of Biomedical Materials Research, 1997
- Poly(α-hydroxy acids): carriers for bone morphogenetic proteinsBiomaterials, 1996
- Controlled release of TGF-β1 from a biodegradable matrix for bone regenerationJournal of Biomaterials Science, Polymer Edition, 1994
- Rapid publication TGF-β1 induces bone closure of skull defectsJournal of Bone and Mineral Research, 1991
- Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) MicrospheresPharmaceutical Research, 1991
- Transforming Growth Factor-β Stimulates Bone Matrix Apposition and Bone Cell Replication in Cultured Fetal Rat Calvariae*Endocrinology, 1990
- In VivoStimulation of Bone Formation by Transforming Growth Factor-βEndocrinology, 1989